CClinicalTrials.gg
CompletedNCT05204030Updated Jul 27, 2026

Hashtag HPV: HPV Vaccine Twitter Education Program

An interventional study of HPV Twitter Education Program - Narrative and HPV Twitter Education Program - Non-Narrative in Human Papilloma Virus and Vaccine-Preventable Diseases, sponsored by University of Arkansas, Fayetteville. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-27.

Sponsored by University of Arkansas, Fayetteville · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Parents use social media as an important parenting tool and source for health information. Using social media data to examine public opinion has had an early impact in public health and in cancer control and prevention efforts, including about the human papillomavirus (HPV) vaccine. A next step in this area of research is to develop and share messages on social media with parents to help inform and educate them about the HPV vaccine - ultimately assisting them with their decision to vaccinate their child. This study will evaluate the efficacy of social media messages through Twitter, using a randomized controlled trial to determine what types of messages resonate with parents. The investigators will examine differences between two types of messages - narrative messages (i.e., stories) and non-narrative messages (i.e., numbers and facts).

Read the detailed description

Approximately 80 million people in the United States - or about one in four - are infected with human papillomavirus (HPV). HPV can cause cancer and there are vaccines that protect against cancer-related strains. Evidence supporting vaccine efficacy and safety is robust, and vaccine availability is widespread; however coverage rates continue to fall short of the national goal of 80% (48.6% in 2017). Understanding the barriers to vaccine acceptance, particularly related to parent resistance and their informational needs, is key to strengthening vaccine uptake among adolescents. Communicating evidence to parents and engaging them through narrative strategies may address some of the barriers during the decision-making process. Parents use social media as an important parenting tool and useful source for health information. In 2015, 75% of all parents used social media, and of these 1 in 4 used Twitter - equating to millions of parent users. The investigators know that using social media data for surveillance has had early impact in public health. However, what is not known is the effectiveness of using large-scale social media data to inform a targeted social media intervention to support HPV vaccine uptake. This study will advance the growing field by evaluating the efficacy of an innovative narrative-focused intervention designed to communicate evidence and information about the HPV vaccine for parents who use social media as a health information source. The approach is informed by narrative engagement theory that posits narratives strengthen knowledge and promote engagement through storytelling by tapping into feelings of empathy, identification, and transportation. The investigators will evaluate the efficacy of our Twitter-based pilot intervention in a randomized controlled trial that will enroll 600 parents/caregivers of children ages 9-14, whose child(ren) has not started the vaccine series. Our central hypothesis is that exposure to narrative-focused exemplar messages will lead to greater intention to vaccinate, and subsequently increased rates of vaccination in the intervention group compared to parents in the comparison group, who receive non-narrative HPV vaccine information (i.e., existing HPV vaccine information developed for Twitter). The investigators will use a Twitter-based Community Advisory Board, virtual focus groups, and existing Twitter messages developed by the HPV Roundtable to inform narrative-focused message development. The proposed study will address three specific aims: 1) Develop narrative-focused scientific exemplars for HPV vaccine communication utilizing existing online messages and community engagement on Twitter; 2) Quantify differences in engagement, intention to vaccinate, and self-reported vaccination between parents exposed to the narrative-focused scientific exemplars and parents exposed to non-narrative scientific messages; 3) Collect and analyze longitudinal participant metadata to measure Twitter activity during the study period. This study will impact the field of cancer prevention generally and HPV vaccination specifically by establishing the efficacy of narrative-focused health messaging campaign on social media, using a Twitter-based parent-engagement strategy.

02

Conditions studied

  • Human Papilloma Virus
  • Vaccine-Preventable Diseases

Keywords

  • Human Papilloma Virus
  • Human Papilloma Virus Vaccine
  • Human Papilloma Virus Vaccination
  • Intervention
  • Social media
  • Twitter
  • Parents
  • Child health
  • Cancer prevention
  • Vaccine acceptance
  • Narrative engagement
  • Patient self-report
  • Intention to vaccinate
  • community engagement
  • Public Health
  • Vaccination
03

In context

Vaccine-Preventable Diseases

51 studies on the registry are indexed under Vaccine-Preventable Diseases; 13 are open to participants now.

This study's enrollment of 28 is below the median of 165 across 38 interventional studies indexed under Vaccine-Preventable Diseases.

Browse Vaccine-Preventable Diseases studies →

Lead sponsor

University of Arkansas, Fayetteville is the lead sponsor of 29 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: The study population includes parents who have children ages 9-14. All participants will be 18 years of age or older, and we will specifically target parents ages 25 and older. Eligibility for enrollment in the study will be limited to the following criteria:

  1. Adults 18 years of age and older;
  2. Utilizes Twitter, a social media platform;
  3. Has a child aged 9-14;
  4. Child has not started the 2-dose HPV vaccination series;
  5. Has no child who has completed any dose HPV vaccination series;
  6. Has a well-care visit scheduled for their child before December, 2022.

Exclusion Criteria:

  1. Any adult who does not have a child 9-14 years of age;
  2. Any adult who does not indicate some level of participation in Twitter;
  3. Any adults who indicates a high level of anti-vaccine sentiment (assessed by vaccine hesitancy questions asked in the screener).
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
28 participants (actual)

Study arms

  • Experimental
    Narrative

    The intervention condition will present narrative-focused messages about HPV and the HPV vaccine that includes important parent focused exemplar language and cultural norms on Twitter told through stories and characters (i.e., pseudo-parents).

    Other: HPV Twitter Education Program - Narrative

  • Active comparator
    Non-Narrative

    The non-narrative condition will present scientific-focused messages about HPV and the HPV vaccine that includes important information relayed with numbers and facts.

    Other: HPV Twitter Education Program - Non-Narrative

Interventions

  • OtherHPV Twitter Education Program - Narrative

    This study will evaluate the efficacy of social media messages through Twitter, using a randomized controlled trial to determine what types of messages resonate with parents. The investigators will examine narrative messages (i.e., stories). The central hypothesis is that parents who read narrative-focused messages will be more likely to report narrative engagement, intention to vaccinate their child, and self-reported vaccination compared to parents who read non-narrative messages.

  • OtherHPV Twitter Education Program - Non-Narrative

    This study will evaluate the efficacy of social media messages through Twitter, using a randomized controlled trial to determine what types of messages resonate with parents. The investigators will examine non-narrative messages (i.e., scientific information - numbers and facts). The central hypothesis is that parents who read narrative-focused messages will be more likely to report narrative engagement, intention to vaccinate their child, and self-reported vaccination compared to parents who read non-narrative messages.

06

What researchers measure

Primary outcomes

  1. Change in caregiver self-reported HPV vaccination status of child questionnaire

    dependent variable; measure collects date of vaccination and number of vaccine doses to date

    Time frame: Change in caregiver self-reported HPV vaccination of child at 1-month follow-up from baseline

  2. Change in caregiver self-reported HPV vaccination status of child questionnaire

    dependent variable; measure collects date of vaccination and number of vaccine doses to date

    Time frame: Change in caregiver self-reported HPV vaccination of child at 1-year follow-up from 1-month follow-up

Secondary outcomes

  1. Caregiver self-reported empathy subscale adapted from Busselle & Bilandzic (2009) and Murphy, Frank, Chatterjee, Baezconde-Garbanati (2013).

    mediating/moderating variable

    Time frame: only at 1-month post intervention

  2. Caregiver self-reported transportation subscale adapted from Murphy, Frank, Chatterjee, Baezconde-Garbanati (2013). Narrative versus Non-narrative: The Role of Identification, Transportation and Emotion in Reducing Health Disparities.

    mediating/moderating variable

    Time frame: only at 1-month post intervention

  3. Caregiver self-reported identification subscale adapted from Murphy, Frank, Chatterjee, Baezconde-Garbanati (2013). Narrative versus Non-narrative: The Role of Identification, Transportation and Emotion in Reducing Health Disparities.

    mediating/moderating variable

    Time frame: only at 1-month post intervention

  4. Change in caregiver self-reported intention to vaccinate their child questionnaire

    dependent variable; measures readiness and likeliness to receive HPV vaccination

    Time frame: Change in caregiver self-reported intention to vaccinate their child at 1-month follow-up from baseline

  5. Change in caregiver self-reported intention to vaccinate their child questionnaire

    dependent variable; measures readiness and likeliness to receive HPV vaccination

    Time frame: Change in caregiver self-reported intention to vaccinate their child at 1-year follow-up from 1-month follow-up

07

Study locations

1 site
  • University of Arkansas
    Fayetteville, Arkansas 72701, United States
08

References and documents

Publications

  • Massey PM, Kearney MD, Hauer MK, Selvan P, Koku E, Leader AE. Dimensions of Misinformation About the HPV Vaccine on Instagram: Content and Network Analysis of Social Media Characteristics. J Med Internet Res. 2020 Dec 3;22(12):e21451. doi: 10.2196/21451. PubMed 33270038 ↗
  • Massey PM, Togo E, Chiang SC, Klassen AC, Rose M, Manganello JA, Leader AE. Identifying HPV vaccine narrative communication needs among parents on social media. Prev Med Rep. 2021 Jul 7;23:101488. doi: 10.1016/j.pmedr.2021.101488. eCollection 2021 Sep. PubMed 34295614 ↗
  • Massey PM, Chiang SC, Rose M, Murray RM, Rockett M, Togo E, Klassen AC, Manganello JA, Leader AE. Development of Personas to Communicate Narrative-Based Information About the HPV Vaccine on Twitter. Front Digit Health. 2021 Aug 4;3:682639. doi: 10.3389/fdgth.2021.682639. eCollection 2021. PubMed 34713151 ↗

Individual participant data

Plan to share: No — There is not a plan to make IPD available.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05204030
Lead sponsor
University of Arkansas, Fayetteville
Collaborators
Thomas Jefferson University, University at Albany, National Cancer Institute (NCI), University of California, Los Angeles
Responsible party
Sponsor
First posted
Jan 24, 2022
Start date
Dec 13, 2021
Primary completion
Feb 29, 2024
Completion
Aug 30, 2024
Last update
Jul 27, 2026

Study contacts

Philip M Massey, PhD, MPH
study director · University of California, Los Angeles

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion